Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-02
2009-06-09
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S369000
Reexamination Certificate
active
07544687
ABSTRACT:
The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia.
REFERENCES:
patent: 6194446 (2001-02-01), Dominianni et al.
patent: 6506781 (2003-01-01), Cobb et al.
patent: 1321152 (2001-11-01), None
patent: 2000344748 (2000-12-01), None
patent: 03059895 (2003-07-01), None
patent: 2004067495 (2004-08-01), None
patent: WO03066574 (2006-12-01), None
Reynolds et al. Tetrahedron, vol. 57, p. 7765-7770 (2001).
Vippagunta et al. Advanced Drug Delivery Reviews, vol. 48, p. 3-26 (2001).
Kevin G. Liu et al. , Synthesis and Biological Activity of L-Tyrosine-Based PPARγ Agonists With Reduced Molecular Weight,(2001), pp. 3111-3113, Bioorganic & Medicinal Chemistry Letters 11,Elsevier Science Ltd.
Yi Xiang and Guo Zong-Ru, Study on 3D-QSAR of PPARγ Agonists With Thiazolidinedione and Arylketo-Acid Moieties,(2001),36 (4) pp. 262-268, Acta Pharmaceutica Sinica China.
Cai Zhe-Feng and Guo Zong-Ru, Peroxisome Poliferator-Activated Receptors and There Modulators, (2004) 39 (2) pp. 158-160, Acta Pharmaceutica Sinica China.
Cheng Feng, et al., Research Progress in PPARγ Agonists, (2003), vol. 13 No. 2 p. 110, Chinese Journal of Medicinal Chemistry.
Cui Hao
Li Song
Lin Cuifang
Liu Hongying
Ruan Chengmai
Beijing Molecule Science and Technology Co., Ltd
Bernhardt Emily
Lucas & Mercanti LLP
LandOfFree
Substituted α-piperazinyl phenylpropionic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted α-piperazinyl phenylpropionic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted α-piperazinyl phenylpropionic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4125503